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Abstract Diabetic peripheral polyneuropathy is characterized by axonal degeneration
and regeneration as well as by Schwann cell and microvascular changes. These changes
have been described at both the light (LM) and the electron microscopic (EM) levels;
however, EM has not been applied to large clinical trials. Our goal was to adapt the
rigorous techniques used for quantifying human biopsies with LM image analysis to
accommodate ultrastructural analyses. We applied digital image capture and analysis to
the ultrastructural examination of axons in sural nerve biopsies from diabetic patients
enrolled in a multicenter clinical trial. The selection of sural nerve biopsies was based on
the quality of specimen fixation, absence of physical distortion, and nerve fascicle size
(100 000; 425 000 mm2). Thin sections were collected on formvar-coated slot grids,
stabilized with carbon and scanned on a Phillips CM100 transmission electron microscope.
Digital images were captured with a Kodak Megaplus 1.6 camera. A montage was
constructed using software derived from aerial mapping applications, and this virtual
image was viewed by EM readers. Computer-assisted analyses included identification
and labeling of individual axons and axons within regenerating clusters. The average
density of regenerating myelinated axon clusters per mm2 was 65.8 5.1, range of
0–412 (n¼ 193). These techniques increase the number of samples that may be analyzed
by EM and extend the use of this technique to clinical trials using tissue biopsies as
a primary endpoint.
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Introduction
Diabetes mellitus affects over 16 million people in
the US, and the number of people with diabetes
increases by 5% per year (Herman et al., 1984). Up
to half of these patients develop diabetic polyneuro-
pathy (DPN) over the course of their disease (Greene
et al., 1997). DPN is characterized by degeneration
and attempted regeneration of myelinated and unmye-
linated axons (Black and Lasek, 1980; Said et al., 1983;
Dyck et al., 1986; Llewelyn et al., 1988; 1991; Said,
1996). Over time, regeneration fails to keep pace
with the degenerative process, resulting in a decrease
in the number of myelinated nerve fibers per mm2
(myelinated nerve fiber density, MNFD), distal loss
of sensation, and muscle weakness (Greene et al.,
1997).
Patient treatment is aimed at preventing fiber loss,
with consequent amelioration of signs and symptoms.
Measurements to assess treatment effectiveness
include nerve conduction testing (Stevens et al.,
1993b; Comi et al., 1999), sensory testing (Stevens
et al., 1993b), and nerve morphology (Feldman et al.,
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1994a; 1994b; Greene et al., 1997). Morphological
parameters examined in sural nerve biopsies include
MNFD, myelinated fiber size frequency histograms,
and teased fiber analysis. These methods monitor the
myelinated fiber populations affected by diabetes
(Feldman et al., 1994a; 1994b; Greene et al., 1997)
and help define the degree of damage. Previous light
microscopy studies in both human diabetic patients
and animal models of diabetic neuropathy report mod-
est increases in MNFD in response to treatment (Sima
et al., 1988; 1993b); however, it is not clear from these
investigations as to how MNFD is maintained. Treat-
ment may increase MNFD over time by decreasing the
number of degenerating axons, increasing the number
of regenerating axons, or a combination of the two.
Regenerating myelinated nerve fibers are defined
as multiple, myelinated fibers surrounded by a com-
mon basal lamina (Sima et al., 1988; Britland et al.,
1990; Greene et al., 1997). This definition derives
from the observations of degeneration and regener-
ation in the peripheral nervous system (Greene et al.,
1997; Sima et al., 1988; Britland et al., 1990). The
original healthy myelinated fiber is surrounded by mye-
linating Schwann cells (SCs) that create and support an
encircling basal lamina. Following axonal damage, the
SCs de-differentiate and undergo mitosis to form a
Büngner Band comprised of dividing SCs within the
original basal laminar tube. Contact by growing axonal
projections induces the surrounding SCs to differen-
tiate and begin myelination. This process results in
multiple axon sprouts in varying states of regrowth
and myelination residing within the original basal laminar
tube. As the new fibers mature, the original basal
lamina is lost, leaving a group of small myelinated
fibers, each with its own basal lamina, in the place of
the original nerve fiber.
Because the thickness of the basal lamina is below
the resolution of light microscopy (LM), electron micro-
scopy (EM) is necessary to fully examine the morpho-
logical characteristics of regenerating axons and
accurately determine their number and relation to the
basal lamina. LM analysis of regenerating axons can-
not distinguish between true regeneration contained
within a continuous basal lamina and small randomly
grouped myelinated fibers. Several studies have docu-
mented the power of EM analysis to assess nerve
regeneration (King et al., 1989; Britland et al., 1990;
Llewelyn et al., 1991; Malik et al., 2001); however, this
has only been applied to small numbers of patients. To
apply this powerful technique to clinical trials, it is
necessary to overcome two main obstacles: (1) cre-
ation of reproducible, understandable definitions for use
by a large data collection team and (2) faster image
capture and analyses to allow for processing of large
groups of patient samples.
In the current study, a set of definitions based on
the literature were developed and tested to train a
group of EM readers with varying levels of experience
and expertise. Images were collected using a digital
camera and computer-driven stage to record the entire
cross-sectional area of a given fascicle. The separate
images were then combined to form a high-resolution
‘virtual’ image of the fascicle and presented to the
readers via image analysis software. To our know-
ledge, this is the first application of digital technology
to the ultrastructural study of a human nerve disease.
We believe that this type of detailed anatomical infor-
mation will provide insight into the processes of dis-
ease and recovery and will support the development of
new treatment strategies and future therapeutic inter-
ventions. In addition, these techniques are applicable




The patients participating in the current study were
type I and type II diabetics with symptoms of neuro-
pathy but measurable sural and peroneal responses
and quantitative vibration thresholds. Sural nerve biop-
sies were obtained at the beginning of the treatment
period and following 12 months of treatment. Patient
selection criteria have been described in detail else-
where (Sima et al., 1993a; Albers et al., 1996a;
1996b; Greene et al., 1999).
Biopsy processing
Sural nerve biopsies were collected from patients
with DPN as part of a multicenter clinical study.
Following surgery, the sural nerve was divided into
1-cm segments and placed in 0.1 M cacodylate buffer
(pH 7.3) containing 2.5% glutaraldehyde. Upon arrival
at the University of Michigan, the sample received
a four-digit randomized identification number (RIN)
to assure that the technicians and analysis team
remained unaware of the treatment group. A segment
designated for morphological analysis was subdivided
into four segments and placed in fresh fixative for
1–2 h prior to automated processing including rinses,
osmification, and dehydration. In brief, the sample was
rinsed with 0.1 M cacodylate buffer (pH 7.3, 2, 15 min)
followed by osmification with 1% osmium [4%
sucrose, 1.5% K3Fe(CN)6] in cacodylate buffer. Follow-
ing additional rinses in cacodylate buffer, the nerve
sample was dehydrated through ethanol (50–100%)
followed by propylene oxide (PO), PO : Epon 812,
1 : 1, and finally Epon 812 alone. Segments were
oriented cross-sectionally to the cutting surface of
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the block, embedded in Epon 812, and cured (48 h at
40 C). One micrometer sections were cut on an ultra-
microtome and stained with toluidine blue for initial
inspection (Perkins et al., 2001).
Fascicle selection and grid preparation
A nerve fascicle is defined as a bundle of myelin-
ated and unmyelinated fibers surrounded by a dense
layer of continuous, convex connective tissue, the
perineurium. The human sural nerve contains as
many as 15 fascicles (Fig. 1). Prior studies have estab-
lished that the MNFD of the largest fascicle is repre-
sentative of whole-nerve MNFD, provided the area of
the fascicle studied is larger than 100,000mm2 (Greene
and Brown, 1995; Perkins et al., 2001). As part of the
LM analysis, a fascicle selection procedure was imple-
mented to assure the quality of a sample. Samples
containing preparation artifacts were not included for
analysis. Criteria for fascicle rejection include: 6%
deviation from circularity and 6% of the myelinated
fibers distorted by surgical trauma or incomplete fix-
ation. To be considered for analysis, a fascicle had to
be at least 100,000 mm2 in area. For consistency, the
largest, artifact-free fascicle was always selected. A
fascicular area >450,000 mm2 or a maximum diameter
of 730 mm was an added criterion to ensure that the
entire fascicle was visible when placed on a slot grid.
Thin sections in the 80–90 nm range (silver–gold
interference color) were prepared using a Diatome
diamond knife (Diatome US, Ft. Washington, PA)
on a Reichert-Jung Ultracut E microtome (Leica Inc.,
Deerfield, IL). A single section was floated onto a
2 1 mm formvar-coated copper slot grid stabilized
with evaporated carbon film (Electron Microscopy
Services, Inc., Fort Washington, PA). Five grids were
collected per sample. To enhance contrast, each grid
was stained with uranyl acetate and lead citrate. The
grids were then stabilized by sublimating spectro-
graphically pure carbon (Ted Pella, Inc., Redding, CA)
using the rotating stage of a Denton Model DV-502
vacuum evaporator (Denton, Moorestown, NJ).
Digital image collection
The stained and stabilized grid was placed in a
Philips CM-100 transmission electron microscope
(North American Philips Co., Mahwah, NJ) fitted with
a Kodak Megaplus Camera, Model 1.6 (Eastman Kodak
Co., Motion Analysis Systems Division, San Diego,
CA). The movement of the grid was controlled using a
computer-driven stage (CompuStage, North American
Philips Co., Mahwah, NJ). The sections were exposed
to the electron beam for 2 min prior to image collection
to minimize section shrinkage during image capture.
The digital acquisition software was initialized using the
‘position’ and ‘radius’ controls to position a bounding
circle that surrounded the fascicle. The stage then
stepped in a serpentine pattern with 12% vertical and
18% horizontal overlap to collect an image of the
entire fascicle. The digital camera and stage move-
ment were coordinated to capture an image every
6 s. The average time required to collect a sample
was 2–3 h. Digital images were collected at a magnifica-
tion of 4600.
The resulting individual TIF files were assembled
into a ‘virtual fascicle’ by application of a montaging
program (Vogt et al., 1996; Vogt, 1996). Specialized
object recognition software identified and marked
myelinated axons (Vogt et al., 1996; Vogt, 1996). Fol-
lowing montage construction and axon marking, the
virtual image of the EM sample was presented to the
EM readers on Hewlett Packard workstations using
adapted Visilog software.
Digital cueing procedures for EM samples and EM
analysis
These techniques enabled digital EM imaging of
entire nerve fascicles at sufficient resolution to analyze
the basal lamina. On average, this required 1064
individual digitally captured micrographs per fascicle.
Environmental Research Institute in Michigan (ERIM)
developed software to automatically register the
micrographs into a single image of the entire fascicle
and to automatically identify, or ‘cue’, the locations of
myelinated fibers and clusters of myelinated fibers
from the images.
Figure1. Sural nerve biopsy. A human sural nerve contains
many fascicles. In this sample, fascicles A and B are both
free of artifact and suitable for light (LM) and electron
microscopic (EM) analysis. A would be selected due to its
larger size. bv, blood vessel; L, lipid; P, perineurium.
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Formation of a single virtual image from large
numbers of individual electron micrographs (frames)
required that each micrograph be preprocessed, regis-
tered, and mosaicked. The first step in image prepro-
cessing was to generate a background image that was
divided into each frame to remove beam effects and
phosphor variations. Intensity statistics were gathered
from the entire set of frames and used to compute the
function for contrast stretching. The contrast-stretched
frames were stored as 8-bit images. The registration
process determined the translation required to align
adjacent images and rows of images. An initial transla-
tion was determined from the nominal stage coord-
inates. Subsequent steps refined the estimate, first
using image correlation on sampled frames, then by a
binary tree search on full resolution frames. The rela-
tive positions of horizontal rows of frames were deter-
mined from the best pairwise registration between
frames near the center of the two rows. The construc-
tion of the mosaic image placed all of the registered
frames into a single overall coordinate system and
then divided the resulting image data into non-
overlapping 1024 1024 pixel tiles which comprised
the virtual image. The high-resolution virtual image
was downsampled by eight pixels in both directions
to form a low-resolution image. The low-resolution
image, typically 25 MB in size, was used by the mye-
linated fiber cueing algorithm and for the first stage of
interactive image review.
The myelinated fiber cueing algorithms were based
on operators from mathematical morphology that were
well suited to shape analysis in binary and gray-scale
imagery. The algorithms were tailored to the review pro-
cess. Because there were typically 1000–2000 myelin-
ated fibers in each fascicle, the myelinated fiber cueing
algorithm was designed to locate as many myelinated
fibers as possible without generating false cues that
would be time consuming to correct. Myelinated fiber
cueing was performed by treating the gray-scale intensity
values as a topological surface and locating regions
where the characteristic tower structure of the light
axon interior was surrounded by a dark moat of myelin.
Boundaries were refined by recovering dark regions con-
nected to the myelin extracted in the initial steps. The
results were filtered to remove noise and linear struc-
tures, as well as fibers from adjacent fascicles.
Reader training and fascicle analysis
Development of definitions for object identification
was important in setting a ‘gold’ standard for reader
training and quality control. Standardized definitions of
myelinated fibers, degenerating myelinated fibers, and
regenerating myelinated fiber clusters were derived
from previous studies (Sima et al., 1988; King et al.,
1989; Britland et al., 1990). Previous LM studies have
employed the term ‘myelinated fiber’ when referring to
the myelinated neuronal processes within the periph-
eral nerve. In the current study, the term myelinated
fiber refers to data described and collected at the level
of the light microscope. The term ‘myelinated axon’
refers to data collected or described using EM. The
terms and definitions follow:
Regenerating myelinated axon cluster
These are two or more myelinated axons sur-
rounded by a common basal lamina. The continuity of
the encircling basal lamina must be 90% or greater
(Fig. 3A,C).
Probable myelinated axon cluster
These are two or more myelinated axons sur-
rounded by a common basal lamina less than 90%
complete (Fig. 3B).
Single regenerating/remyelinating axon
This is any single myelinated axon surrounded by
an old and a new basal lamina. The basal lamina must
be 90% complete (Fig. 3C).
Degenerating myelinated axon
This is a myelinated axon characterized by disrup-
tions in or missing axoplasm. Wrinkles or folds in the
myelin were not included due to possible preparation
artifacts (Fig. 3D).
For readers to review these very large virtual
images and record their observations, an interactive
review or reading station was developed by ERIM.
The reader station allowed inspection either of the
low-resolution image or of selected portions of the
high-resolution data. Reader training consisted of an
introduction to the definitions, a review of relevant
images, and instruction on the use of the analysis soft-
ware. A series of test images were presented to the
readers and their identification of objects compared
both as a group and individually with an instructor.
Over the course of the training period, consensus
was achieved by comparing data sets between
trainees and instructors.
A standardized sequence of procedures further
assured reproducibility between readers and consist-
ency of the reading group over time. Each reader
began with a low-resolution survey of the area outside
the main fascicle, the perineurium, and parts of other
fascicles to remove fibers marked during the prelimin-
ary computer analysis. The reader then surveyed the
fascicle for errors made by the myelinated fiber mark-
ing software and corrected these errors. Potential clus-
ters or objects too small to identify were marked with
an area of interest (AOI) mark. To make sure that all
areas of the fascicle had been examined, a box enclos-
ing a specific region was stepped across the fascicle.
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The high-resolution data could not be accessed until
the reader completed the stepping function. The high-
resolution scan consisted of an examination of each
AOI. Following the identification of the object in ques-
tion, the AOI mark was removed and the reader
moved on to the next AOI. When all of the AOI
marks were removed, the image reading was com-
plete and the data set, including the myelinated axon
and cluster marks, was transferred into the database.
Quality control
A subset of samples was read by two readers either
internal or external to the study to address issues of
reader variability. The difference between readers was
not to exceed 5% for myelinated fiber counts and 10%
for regenerating myelinated cluster counts. For internal
quality control, a 20% subsample of the EM sections
was randomly chosen and reassigned to a second
internal reader. In addition, 10% of the samples were
sent to another site for external quality control. A group
of 24 randomly selected samples were resectioned,
scanned, montaged, and read by the original reader
to identify any changes in technical processing over
the course of the study.
Results
Fascicle selection
The current study demonstrates the feasibility of
applying digital imaging technology to the quantifica-
tion of human sural nerve biopsies. As outlined in the
Materials and Methods, careful examination of each
biopsy ensured that only the fascicles meeting specific
quality standards were examined. Application of fas-
cicle selection criteria with regard to fixation and surgical
technique resulted in samples of suitable quality for
EM analysis (Fig. 1). Figure 1 is a representative
example of a biopsy containing multiple fascicles of
varying size. Fascicles A and B were acceptable by the
established criteria with the final selection, fascicle A,
based on fascicular area. Overall, in the 1291 biopsies
received, fascicle and fiber distortions were minimal.
By applying strict selection criteria (see Materials and
Methods), 1153 samples were accepted for LM analy-
sis and 1022 were accepted for EM analysis.
Image collection
The use of slot grids rather than traditional mesh
grids ensured that objects of interest, in this case,
myelinated axon clusters and small myelinated axons,
were not obscured by the structure of the grid. Stand-
ard square mesh grids obscured 35–50% of the speci-
men and may lead to undersampling of rare objects
and of larger objects that are likely to be partially
obscured by grid bars. Digital images were collected
at a magnification of 4600. Specialized software con-
structed a montage from the individual, overlapping
digital image files (Fig. 2). Coordination of the
computer-driven stage and camera ensured that no
image files were omitted, and the resultant montage
contained no distortions, gaps, or serious misalignments
(Fig. 2). The overall result of the applied technology
was a complete digital image of the fascicle of suffi-
cient resolution to discriminate individual basal laminae
necessary to identify regenerating axon clusters. This
process was made more reliable by the application of
carbon to stabilize the grids. Carbon stabilization of the
specimen prior to exposure to the electron beam was
coupled with a pre-image collection exposure to the
electron beam. These procedures were necessary to
maintain sample stability during the 2–3 h of beam
time required to image the entire fascicle and were
added to minimize specimen warping and stretching.
Initial image collection without carbon stabilization and
pre-imaging beam exposure often contained areas of
specimen warping that made adjacent image correl-
ation and alignment with simple translation impossible
(data not shown). Sample stabilization techniques
eliminated the need for second-order (or higher)
polynomial resampling based on the tie points in the
overlapping regions of adjacent images. Tie point
determination and resampling to achieve image
registration would have resulted in an unacceptable
Figure2. A completed montage of an entire sural nerve
fascicle. This image is constructed of over 200 individual
image tiles. Arrow indicates the edges of image tiles.
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increase in image processing time and compromised
image resolution.
Image analysis
As described in Materials and Methods, a myelin-
ated axon cueing algorithm analyzed and annotated
the imagery. This was followed by myelinated axon
correction and cluster identification by trained EM
readers who were responsible for verifying and cor-
recting these marks as well as identifying regenerating
and degenerating myelinated axons according to the
study criteria. Myelinated cluster confirmation as well
as evaluation of other types of regenerative changes
took place during the high-resolution scan (virtual mag-
nification of 15 000). The resulting data or ‘marks’ file
appeared as an overlay of colored squares across the
fascicle.
The reader interface was built using Visilog image
analysis (Noesis Vision, Inc., St-Laurent, Quebec,
Canada) software and was specifically tailored for its
use in analyzing sural nerve biopsies. Myelinated axon
(red), AOI (bright green), and degenerating axon
(yellow) buttons were available for marking in the low-
resolution phase of image analysis. The readers also
used a three-button mouse that contained an erase
feature to facilitate changes. During the high-resolution
phase of analysis, a set of different colored cluster
buttons were available in addition to the standard mye-
linated axon and degenerating axon buttons. These
colors were instituted to aid in marking separate regen-
erating myelinated axon clusters. To annotate the
imagery, the reader would click on the type of myelin-
ated axon (normal, degenerating, or regenerating) on the
side panel, then return to the imagery, and place the
mark over the center of the axon. As the fascicle was
reviewed, marks could be changed; however, once the
reader completed the fascicle, the data were sent to
the database and could no longer be altered.
Normal, regenerating and degenerating axon
analysis
In 407 of 486 cases, the fascicle analyzed by EM
was the same as that analyzed by LM. In 79 samples,
the second largest fascicle (total area within 10% of
the area of the largest) was chosen for EM due to the
selection criteria (see Materials and Methods). When
the same fascicle was analyzed for both LM and EM, it
was possible to compare the total myelinated fiber,
using LM, and myelinated axon, using EM, counts
determined by these techniques. The average number
of myelinated fibers identified by LM was 766 21
(mean standard error) with a range of 51–2899. The
average number of total myelinated axons identified by
EM was 770 21 with a range of 47–2894. The mean
difference between the number of myelinated fibers
and the number of myelinated axons was 3.8 0.8
per fascicle (meanSE), p< 0.0001. Ninety percent
of the differences were no greater than 24 myelinated
fibers or axons (or 3% of the average number). As
expected, the average number of myelinated axons
(EM) identified was slightly higher than myelinated
fibers (LM); however, the difference was only 0.5%
of the average.
Potential regenerating myelinated axon clusters
typically appeared as small, tightly grouped myelinated
fibers in the low-resolution scan. When viewed at high
resolution (15 000), the continuity of the basal lamina
determined cluster classification as definite regenerat-
ing (Fig. 3A,C) or probable regenerating (Fig. 3B). In the
absence of basal lamina, myelinated axons were
counted as normal, single axons. Figure 3 clearly
demonstrates both the quality and the resolution of
the images analyzed in this study. The basal laminae
appear as distinct structures encircling groups of
myelinated axons (regenerating clusters) or as empty
loops and fragments within the fascicle, distinct from
the surrounding collagen, SC debris, and fibroblast
extensions (Fig. 3A–D).
Other types of regenerative changes included sin-
gle myelinated axons surrounded by multiple layers of
basal lamina and myelinated axon clusters containing
only one myelinated but several unmyelinated axons
(Fig. 3C). Single myelinated axons with more than one
basal lamina layer may be due to demyelination
followed by remyelination; however, they lacked the
layers of SCs and SC debris typical of onion bulb for-
mation. When detected, these myelinated axons were
labeled single clusters. Axon clusters containing a sin-
gle myelinated and several unmyelinated axons were
given no special designation, and only the myelinated
axon was counted. Both of these myelinated axon
categories appeared as normal, single myelinated
axons in the low-resolution scan and were discovered
only incidentally while viewing the imagery at high
resolution. Therefore, while these fibers were noted
in the database, their frequency could not be quanti-
fied. The end stages of degenerating myelinated
axons, characterized by loss of axoplasm and presence
of myelin debris were visible at low resolution as dark
axons and were confirmed and quantified at high
resolution (Fig. 3D).
Quality control
To assess reader variability over the course of the
study, 87 samples were re-assigned and re-read for
internal quality control. Myelinated axon counts did
not vary by more than 5% between the original and
quality control reads. For regenerating myelinated
cluster counts, 23 samples varied between readers by
4 regenerating fiber clusters. Of these differences,
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seven samples were severely discrepant between the
original and quality control read. Thirty-six samples
were sent to another laboratory for external quality
control. Of these, six samples differed by more than
10 regenerating clusters. Twenty-four samples were
re-sectioned, re-imaged, re-masked, and re-analyzed to
assess any changes in sectioning or image processing
that may have occurred over the course of the study.
Of these 24, only four samples varied by more than
four regenerating fiber clusters.
The average density of definite regenerating mye-
linated axon clusters per mm2 was 65.8 5.1 with a
range of 0–412 (n¼ 193). About 8.5% of samples con-
tained no regenerating myelinated axon clusters. The
minimum number of myelinated axons with a regen-
erating cluster was two; however, clusters contained
up to nine myelinated axons, with an average of 2.23
myelinated axons per regenerating cluster. An average
of 10.8 clusters per fascicle contained two myelinated













Figure3. (A) An example of a regenerating myelinated axon cluster containing four myelinated axons in a common basal
lamina (black arrow). Note the presence of an axon in the earliest stages of myelination (white arrow). (B) An example of a
probable myelinated axon cluster in which the axons are tightly grouped but the basal lamina (black arrows) is less than 90%
complete. (C) In addition to standard myelinated axon clusters (a), other types of regeneration are observed including
myelinated and unmyelinated axons (white arrows) within a common basal lamina (b) and single myelinated axons surrounded
by more that one basal lamina (c, black arrow). (D) Degenerating myelinated axons are characterized by loss of axoplasm and
subsequent myelin breakdown. No axoplasm is detected in this degenerating axon and myelin debris is prominent (asterisk).
Black arrows, basal lamina; SC, Schwann cell nucleus. Bar¼ 5 mm.
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0.53 clusters per fascicle contained four or more mye-
linated axons.
Discussion
Early in the course of diabetes, alterations in nerve
metabolism result in nerve ischemia, myelinated fiber loss
and the signs and symptoms of DPN (Stevens et al.,
1996; Greene et al., 1997; Feldman et al., 1997;
Sundkvist et al., 2000). Treatment of patients with
DPN is aimed at preventing fiber loss and reducing or
at least stabilizing neurological deficits. Experimental
treatment for DPN in clinical trials includes compounds
that inhibit the aldose reductase pathway (Greene
et al., 1993; 1999; Sima et al., 1993b; Stevens et al.,
1994; Hotta, 1995), restore essential fatty acids (Zenobi
et al., 1993; Stevens et al., 1993a; Driscoll et al., 1994;
Nickander et al., 1996; Garrett et al., 1997), reduce
oxidative stress (Hellweg and Hartung, 1990; Low and
Nickander, 1991; Wolf, 1993; Cameron and Cotter,
1995; Love et al., 1996), or increase levels of neuro-
trophic molecules (Diemel et al., 1994; Pfeiffer and
Schatz, 1995; Whitworth et al., 1995). Pre- and post-
treatment assessment of neuropathy was based on
electrophysiology and sensory testing as primary end-
points of nerve function (Feldman et al., 1994a; 1994b;
Greene et al., 1997; 1999). Morphologic analysis of
myelinated nerve fibers included teased fiber analysis
and counts of myelinated fibers at the level of the light
microscope (Ochoa and Mair, 1969; Said et al., 1983;
Jacobs and Love, 1985; Dyck et al., 1986; Llewelyn
et al., 1988; Sima et al., 1988) as secondary endpoints.
Measures of glucose metabolites and polyols were also
assessed in trials of aldose reductase inhibitors (Greene
et al., 1998).
Decreases in MNFD and increased abnormal fibers
(teased fiber analysis) have been extensively reported
for DPN (Greene et al., 1997) and are highly correlated
with decreased nerve function and sensory loss
(Greene et al., 1997). In addition, many reports in the
literature describe in detail the ultrastructural changes
that accompany DPN (King et al., 1989; Britland et al.,
1990; Llewelyn et al., 1991; Malik et al., 2001). These
studies were performed by intensive examination of
small numbers of patient samples. While myelinated
fiber analysis yields valuable information concerning
overall MNFD, it cannot make clear distinctions
between normal fibers, degenerating fibers, and
small regenerating fibers. This inability to distinguish
small, regenerating myelinated axons from those
spared by treatment may lead to discrepancies in esti-
mations of myelinated axons undergoing regeneration.
Therefore, our goal was to find a way to combine the
power of EM, the time-saving aspects of digital tech-
nology, and our experience with standardization for
clinical trials. In the current study, we established a
method for the digital collection, analysis and storage
of large images, and data sets necessary for use in
clinical trials and their automated presentation to mul-
tiple readers. To our knowledge, this is the first clinical
trial to examine this number of human biopsies at this
level of detail.
Our reported myelinated cluster density of
65.8 5.1/mm2 is substantially lower than that
reported by Britland et al. (1990) and Llewelyn et al.
(1991). These differences may be because of multiple
factors including the use of conservative definitions of
regeneration and area sampled. As mentioned above,
the goals of the current study were to optimize proto-
cols by which large numbers of samples could be
analyzed by multiple readers. To this end, a regenerat-
ing myelinated axon cluster was defined as two or
more myelinated axons surrounded by a common
basal lamina that was 90% complete. Definitions of
regeneration in prior studies include Büngner Bands
containing only unmyelinated axons, clusters contain-
ing as few as one myelinated and several unmye-
linated axons (Britland et al., 1990), or two or more
myelinated axons in close apposition with or without
an encircling basal lamina (Llewelyn et al., 1991). It is
clear from our observations and those of others (King
et al., 1989; Britland et al., 1990; Llewelyn et al., 1991)
that total regenerative changes span a broad scope.
The inclusion of ‘probable’ clusters in the database
was an attempt to track other types of regeneration.
Consensus concerning basal lamina integrity below
90% was not possible to achieve in the study time
frame. Therefore, the probable classification was
added to re-address these clusters if further analysis
was warranted. While the definitions used in the cur-
rent study characterize only one stage of regeneration,
the data are available for further in depth analysis
based on the results of treatment, positive or negative,
or other signs and symptoms reported by patients or
clinicians involved in the study. Thus, our data provide
a deeper examination of the anatomical effects of dis-
ease and treatment with the added benefit that further
analysis does not require resampling of the patients or
reprocessing of samples.
We believed that because regenerating clusters
would be rare and their distribution across a given
fascicle was unknown, it was important to sample as
large an area as possible. Analysis of the largest
fascicle was chosen to take advantage of the known
myelinated fiber densities gathered by LM. This meas-
urement paradigm has been implemented in other
drug trials (Perkins et al., 2001) with statistically
significant results. While previous studies described
in detail the type of regenerative changes examined,
little detail was included concerning the sampling
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procedure. Sampling paradigms for LM include analy-
sis of the largest fascicle, random frame grabbing, and
counting all possible frames (Tomlinson and Mayer,
1984; Britland et al., 1990; Llewelyn et al., 1991). Digi-
tal EM could accommodate many of these sampling
paradigms. Multiple fascicles may fit onto 1.5 2 mm
slot or 2.0 mm hole grids. In this way, several fascicles
could be imaged or random frames collected by setting
the stage to sample at a given spatial interval.
Previous EM examinations of nerve biopsies have
been limited by the use of copper mesh grids (Sima
et al., 1988; Britland et al., 1990; Greene et al., 1997),
photographic imaging (Sima et al., 1988; Britland et al.,
1990; Greene et al., 1997), and the time needed for
these processes. Up to 50% of the imagery is
obscured by copper mesh grids. Traditional photo-
graphic methods of image capture on EM film would
result in 150–200 negatives to develop and sub-
sequently print as 8 10 photomicrographs. These
photomicrographs would then have to be physically
mosaicked and analyzed by visual inspection and man-
ual data compilation. The resulting photographic mont-
age would be approximately 30 feet in diameter. The
overall time required for analysis at the EM level is
somewhat longer than the time for analysis at the
light level. In general, tissue processing is the same
for both types of analyses, as adequate resolution is
only achieved by plastic sections. LM analysis is per-
formed semi-automatically by scanning and analyzing
at the same time, frame by frame. The advantage is
that image capture and analysis are concurrent and the
disadvantage is that the work station must be con-
stantly attended and the program uninterrupted from
start to finish. This procedure can take anywhere from
2 to 8 h to complete, depending on the size of the
fascicle measured.
In EM analysis, image capture, processing, and
automated analysis can take from 3 to 8 h followed
by interactive analysis which can take from 2 to 5 h.
The added time may be prohibitive for some studies;
however, the depth of analysis made possible by
capturing high-resolution ultrastructure cannot be over-
estimated and additional LM analysis would not be
required. The current study used simple definitions to
define regenerative clusters to assure consistency and
to expedite the analyses. A deeper analysis of the data
may be performed on a subset of entire fascicles or on
a limited number of frames from all the fascicles in the
study. This work could be performed by more highly
trained personnel and form the basis for future defin-
itions and study endpoints. For example, regenerating
clusters may be further defined by the number of
sprouts within a cluster, the total myelinated axon
size and myelin thickness, and the completeness of
the basal lamina. These characteristics may be used to
determine the difference between newly formed
regenerative clusters (complete basal lamina and
higher number of fiber sprouts) and those that are
more mature (basal lamina breaking down and fewer
fiber sprouts) (King et al., 1989; Britland et al., 1990;
Llewelyn et al., 1991; Sundkvist et al., 2000). Addition-
ally, algorithms could be developed to relate the
location of regenerating clusters to other structures
including degenerating myelinated axons and blood
vessels as well as distance from the perineurium and
each other. Taken together, these data allow for com-
parisons of rates of degeneration to regeneration in
response to treatment. When applied to animal stud-
ies, these techniques and analyses may help model
diffusion and availability of drugs or growth factors in
future preclinical pharmaceutical trials. In addition to
regenerative cluster analysis, axon size and myelin
thickness could be assessed by applying new algo-
rithms to the existing data set. In this way, demyelin-
ation could also be assessed.
The EM readers for the study included three Ph.D.
level anatomists and an EM technician with 10 years of
experience. This group easily identified axons in vari-
ous stages of degeneration and regeneration at high
resolution. However, the features of these axons could
not be assessed during the initial low-resolution scan.
This was also problematic for some regenerative axon
clusters. The readers learned to err on the side of
caution and place AOI marks on any group of axons
that even remotely appeared as though it may be an
axon cluster. This point emphasizes the need for a
multi-tiered analysis strategy. This could easily be
implemented by extending the training of the initial
analysis team or by sending selected images to
experts in the field of neuropathology.
Quality control was maintained over the course of
the study by the application of standardized reader
training and reading procedures. This included a 6–8-
week reader training period during which the readers
were familiarized with the imagery to be analyzed as
well as the software to be used. Readers were not
allowed to collect data until certified by the project
statistician. This process involved comparison of the
reader’s data set to an instructor data set collected
from a specific set of images. Requirements for certi-
fication include agreement within 5% for total fiber
counts and agreement within 10% for total regenerat-
ing cluster counts.
Recent advances in existing image analysis
software including MetaMorph (Universal Imaging,
Downington, PA) and Image-Pro (Media Cybernetics,
Silver Spring, MD) may make this process available to
a wider group of scientists. When applied to clinical
trials, great care must be taken to ensure consistency
in all aspects of data collection from processing and
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preparation of samples, instrumentation, and reader
training. For both large and small studies, automated
image analysis greatly reduces fatigue and provides a
direct link between data collection and storage, as the
data can be analyzed by the image analysis software
or directly exported to Excel or a similar data handling
software. These techniques apply to any disease
model in which biopsies are routinely analyzed.
The above described methods and results indicate
that digital analyses of human sural nerve biopsies are
possible and feasible. The degree of analysis may be
extended beyond the current work by examining the
entire nerve rather than the largest fascicle and/or by
analyzing selected frames in more detail than outlined
here. In summary, the use of digital EM, a powerful
computer-assisted image analysis and multiple readers
for data collection, enabled the ultrastructural examin-
ation of important regenerative changes in a multi-center
clinical trial. Future examinations of this and other
archived biopsy material could include investigations
of all types of regenerative changes as well as an exam-
ination of the number and condition of the unmyelinated
fibers. Study of placebo-treated patients in addition to
experimentally treated patients will greatly contribute to
our understanding of the progression of DPN and the
ultrastructural underpinnings of drug therapies.
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